Page 16 - 69404d10 News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Foundations Investment Advisors LLC bought a new stake in Pacific Biosciences of California, Inc. (NASDAQ:PACB – Get Rating) in the fourth quarter, Holdings Channel.com reports. The institutional investor bought 10,688 shares of the biotechnology company’s stock, valued at approximately $154,000. A number of other hedge funds and other institutional investors have also bought and sold […]

StockNews.com upgraded shares of Pacific Biosciences of California (NASDAQ:PACB – Get Rating) to a sell rating in a report published on Tuesday morning. Several other research firms have also issued reports on PACB. Piper Sandler cut their price target on Pacific Biosciences of California from $20.00 to $13.00 in a report on Tuesday, March 1st. […]

Shares of Pacific Biosciences of California, Inc. (NASDAQ:PACB – Get Rating) fell 3.7% on Friday . The company traded as low as $10.32 and last traded at $10.53. 65,616 shares changed hands during trading, a decline of 99% from the average session volume of 4,776,942 shares. The stock had previously closed at $10.93. A number […]

Pacific Biosciences of California (NASDAQ:PACB – Get Rating) and Cue Health (NASDAQ:HLTH – Get Rating) are both medical companies, but which is the superior stock? We will contrast the two businesses based on the strength of their profitability, analyst recommendations, institutional ownership, risk, valuation, earnings and dividends. Insider & Institutional Ownership 92.9% of Pacific Biosciences […]

Abacus Planning Group Inc. cut its holdings in shares of Pacific Biosciences of California, Inc. (NASDAQ:PACB – Get Rating) by 13.9% during the fourth quarter, HoldingsChannel.com reports. The firm owned 155,000 shares of the biotechnology company’s stock after selling 25,000 shares during the quarter. Pacific Biosciences of California makes up 0.8% of Abacus Planning Group […]